RT Journal Article
SR Electronic
A1 Vinall, Phil
T1 54 Week Results from IMPACT 2: Infliximab Inhibits Progression of Radiographic Damage in Patients with Active Psoriatic Arthritis
JF MD Conference Express
YR 2006
FD SAGE Publications
VO 6
IS 3
SP 15
OP 15
DO 10.1177/155989770600600309
UL http://mdc.sagepub.com/content/6/3/15.1.abstract
AB Psoriatic arthritis (PsA) is a chronic inflammatory arthropathy condition characterized by an association of arthritis and psoriasis that can lead to progressive joint damage, disability, and reduced life expectancy [Rheumatol 2003;42:1460—8]. Using data from the 54 week IMPACT 2 trial data, this article assesses the effect of IFX 5mg/kg compared with a placebo on structural damage in 200 PsA patients.